Rubicon Research Ltd.
₹1,798.8
-5.3 (-0.3%)
RUBICON Share Price
As on August 19, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 29,647 Cr
P/E Ratio120.36
Dividend Yield0.08 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open1,820
High1,820.1
NSE SymbolRUBICON
Close1,798.8
Low1,730.8
BSE Symbol544578
Previous Years High/Low
1 Year High1,820.1
3 Year High1,820.1
5 Year High1,820.1
1 Year Low570.75
3 Year Low570.75
5 Year Low570.75
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,728.28 | Bullish |
| 10-DMA | 1,663.3 | Bullish |
| 20-DMA | 1,594.04 | Bullish |
| 50-DMA | 1,470.59 | Bullish |
| 100-DMA | 1,211.32 | Bullish |
| 200-DMA | 954.98 | Bullish |
Historical Performance
1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 17,540 | 12,843 | 8,539 | 3,935 | 3,136 |
| Total Expenditure | 13,547 | 10,283 | 6,993 | 3,750 | 3,528 |
| Other Income | 87 | 119 | 185 | 255 | 168 |
| Operating Profit | 4,080 | 2,679 | 1,731 | 440 | -224 |
| Interest | 422 | 368 | 313 | 190 | 97 |
| Depreciation | 453 | 366 | 390 | 361 | 340 |
| Profit Before Tax | 3,205 | 1,945 | 1,029 | -110 | -661 |
| Consolidated Net Profit | 2,467 | 1,344 | 910 | -169 | -671 |
| Adjusted EPS | 15 | 9 | 6 | -1 | -4 |
Compounded Sales Growth
10 Years:93.2
5 Years:41
3 Years:34.8
TTM:6.4
Compounded Profit Growth
10 Years:310.3
5 Years:51.7
3 Years:38.3
TTM:12.9
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:-4.4
3 Years:6
last year:14.9
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 120.36, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered price CAGR data is unavailable.
- The stock carries a low beta of 0.4, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹4080 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹17540 million, indicating a large and established business.
Investment Calculator
₹
Investment Amount: ₹
Current Value: ₹
No. of Shares: NaN (Approx)
Performance:%
NIFTY Performance: %
1 day Top Gainers
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
